{"id":"W2752563952","doi":"10.1200/jco.2017.73.3246","title":"First-in-Human Phase I Study of the Tamoxifen Metabolite Z-Endoxifen in Women With Endocrine-Refractory Metastatic Breast Cancer","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"ca_institutions":"Seagen (Canada)","funders":"National Cancer Institute; Pfizer; Eli Lilly and Company","keywords":"Medicine; Tamoxifen; Fulvestrant; Internal medicine; Metastatic breast cancer; Breast cancer; Oncology; Pharmacokinetics; Cancer; Gastroenterology; Pharmacology; Urology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001823865,0.0001775358,0.001946432,0.0001734297,0.00008608522,0.000009693656,0.0004216823,0.00008946577,0.0003967192],"category_scores_gemma":[0.0004140903,0.00009568027,0.0002026211,0.0001284212,0.0003380509,0.0001767795,0.0001011546,0.0009858004,0.000001352591],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003827471,"about_ca_system_score_gemma":0.001233652,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001170771,"about_ca_topic_score_gemma":0.004014911,"domain_scores_codex":[0.9966338,0.0005671503,0.00191262,0.0002082518,0.0003533851,0.0003247973],"domain_scores_gemma":[0.9956343,0.0008344847,0.002650633,0.000410982,0.0002267314,0.0002428924],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02937167,0.0367603,0.8799882,0.00006266203,0.001712029,0.002406221,0.002083519,0.00008612275,0.0006206665,0.00001703986,0.0004533399,0.04643825],"study_design_scores_gemma":[0.07653665,0.02172422,0.8918645,0.0001118974,0.0009300001,0.0002408926,0.0004644492,0.00001587887,0.00006835238,0.0001147179,0.007846452,0.0000820034],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9912048,0.0004041125,8.553014e-7,0.006487004,0.0007739911,0.0005923319,0.00001709743,0.000002685589,0.0005171065],"genre_scores_gemma":[0.9979376,0.0004363625,0.00007442629,0.0006716863,0.0005241108,0.00005740742,3.996203e-7,0.00001729439,0.0002807041],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04716498,"threshold_uncertainty_score":0.4343797,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1239145229701659,"score_gpt":0.5287560360576353,"score_spread":0.4048415130874694,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}